[go: up one dir, main page]

ES2156611T3 - Metodo para acoplar polisacaridos a proteinas. - Google Patents

Metodo para acoplar polisacaridos a proteinas.

Info

Publication number
ES2156611T3
ES2156611T3 ES96203556T ES96203556T ES2156611T3 ES 2156611 T3 ES2156611 T3 ES 2156611T3 ES 96203556 T ES96203556 T ES 96203556T ES 96203556 T ES96203556 T ES 96203556T ES 2156611 T3 ES2156611 T3 ES 2156611T3
Authority
ES
Spain
Prior art keywords
chr
hydrogen
carbamoyl
integer
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96203556T
Other languages
English (en)
Inventor
Peter Hoogerhout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nederlanden Staat
Original Assignee
Nederlanden Staat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Staat filed Critical Nederlanden Staat
Application granted granted Critical
Publication of ES2156611T3 publication Critical patent/ES2156611T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicon Polymers (AREA)
  • Cooling Or The Like Of Semiconductors Or Solid State Devices (AREA)

Abstract

SE PROPONE UN NUEVO METODO PARA ACOPLAR DE FORMA COVALENTE POLISACARIDOS A OTROS BIOPOLIMEROS, UTILIZANDO UN LIGANTE AMINOTIOL REPRESENTADO POR LA FORMULA 1 H{SUB,2}N SUB,M} ,4} UN ENLACE DIRECTO O UN GRUPO DE FORMULA UB,M} NTERO ENTRE 0 Y 5; N ES UN ENTERO ENTRE 0 Y 3; P ES UN ENTERO ENTRE 0 Y 2; Q ES EL ENTERO 0 O 1; R{SUP,1} ES HIDROGENO O UN ALQUILO C{SUB,1}-C{SUB,6}, OPCIONALMENTE SUSTITUIDO POR AMINO, HIDROXILO, CARBOXILO, ALCOXICARBONILO C{SUB,1}-C{SUB,4}, CARBAMOILO, MONO AL} CARBOXIALQUIL)CARBAMOILO, O, SI M 0, R{SUP,1} ES HIDROXILO, AMINO O PEPTIDIL DEPENDIENTE HIDROGENO, O ALQUILO C{SUB,1}-C{SUB,4}, O JUNTOS FORMAN UN GRUPO OXO; R{SUP,4} ES HIDROGENO, ALQUILO C{SUB,1}-C{SUB,4}, CARBOXILO, ALCOXICARBONILO C{SUB,1}-C{SUB,4}, CARBAMOILO, MONO CARBOXIALQUIL)CARBAMOILO; R{SUP,5} ES HIDROGENO, METILO, HIDROXILO, O ACILOXI C{SUB,1}C{SUB,7}; R{SUP,6} ES HIDROGENO O METILO; R{SUP,7} ES HIDROGENO O UN GRUPO PROTECTOR DE TIOL O UN GRUPO DE FORMULA P,4} - [A CR{SUP,2}R{SUP,3} - CHR{SUP,1} {SUB,Q} NH{SUB,2}; Y Z ES IMINO, METILIMINO, OXIGENO O AZUFRE.
ES96203556T 1996-12-16 1996-12-16 Metodo para acoplar polisacaridos a proteinas. Expired - Lifetime ES2156611T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96203556A EP0848011B1 (en) 1996-12-16 1996-12-16 Method of coupling polysaccharides to proteins

Publications (1)

Publication Number Publication Date
ES2156611T3 true ES2156611T3 (es) 2001-07-01

Family

ID=8224703

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96203556T Expired - Lifetime ES2156611T3 (es) 1996-12-16 1996-12-16 Metodo para acoplar polisacaridos a proteinas.

Country Status (12)

Country Link
US (1) US6361777B1 (es)
EP (1) EP0848011B1 (es)
JP (1) JP4619459B2 (es)
AT (1) ATE199908T1 (es)
AU (1) AU5347898A (es)
CA (1) CA2274852C (es)
DE (1) DE69612205T2 (es)
DK (1) DK0848011T3 (es)
ES (1) ES2156611T3 (es)
GR (1) GR3035918T3 (es)
PT (1) PT848011E (es)
WO (1) WO1998027107A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248334B1 (en) * 1997-01-08 2001-06-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process
NZ537735A (en) * 2002-07-03 2006-08-31 Pericor Science Inc Compositions of hyaluronic acid and methods of use
KR101158147B1 (ko) 2003-12-17 2012-07-17 와이어쓰 엘엘씨 Ａβ 면역원성 펩티드 캐리어 컨쥬게이트 및 이의 제조방법
KR101157694B1 (ko) 2003-12-17 2012-06-20 와이어쓰 엘엘씨 면역원성 펩티드 캐리어 컨쥬게이트 및 이의 제조 방법
EP2383035A4 (en) 2008-12-03 2017-11-22 Kaneka Corporation Formyl group-containing porous support, adsorbent using same, method for producing same, and method for producing the adsorbent
US9708413B2 (en) 2012-11-22 2017-07-18 Glytech, Inc. Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof
JP6219308B2 (ja) 2012-11-30 2017-10-25 株式会社糖鎖工学研究所 糖鎖付加リンカー、糖鎖付加リンカーと生理活性物質とを含む化合物またはその塩、及びそれらの製造方法
JP2017505792A (ja) * 2014-02-14 2017-02-23 ファイザー・インク 免疫原性糖タンパク質コンジュゲート
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549051B1 (fr) 1983-06-22 1986-05-16 Centre Nat Rech Scient Nouveaux agents radioprotecteurs ayant une structure amino-thioalkyle et procede pour leur preparation
US4762713A (en) 1983-07-05 1988-08-09 The University Of Rochester Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers
EP0326111A3 (en) * 1988-01-29 1989-12-27 New York Blood Center, Inc. Peptide derivatives rendered immunogenic when administered with alum as an adjuvant
US5738855A (en) * 1994-10-17 1998-04-14 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of typhoid fever vaccine from a plant or fruit polysaccharide

Also Published As

Publication number Publication date
PT848011E (pt) 2001-08-30
EP0848011A1 (en) 1998-06-17
US6361777B1 (en) 2002-03-26
AU5347898A (en) 1998-07-15
EP0848011B1 (en) 2001-03-21
CA2274852A1 (en) 1998-06-25
WO1998027107A8 (en) 2000-01-20
DE69612205T2 (de) 2001-08-30
CA2274852C (en) 2008-06-17
DE69612205D1 (de) 2001-04-26
GR3035918T3 (en) 2001-08-31
WO1998027107A1 (en) 1998-06-25
DK0848011T3 (da) 2001-07-16
JP2001509144A (ja) 2001-07-10
JP4619459B2 (ja) 2011-01-26
ATE199908T1 (de) 2001-04-15

Similar Documents

Publication Publication Date Title
ATE64396T1 (de) Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2156611T3 (es) Metodo para acoplar polisacaridos a proteinas.
NZ542138A (en) Heterobifunctional polymeric bioconjugates
BR9713351A (pt) N-(aril/heteroaril/alquilacetil) aminoácido amidas, composições farmacêuticas compreendendo as mesmas, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese pelo uso de tais compostos
FR17C0003I2 (fr) Steroides comme agonistes de fxr
NO20020725L (no) Celleadhesjonsinhibitorer
MX9803761A (es) Nuevos agentes de transfeccion y sus aplicaciones farmaceuticas.
MX9805289A (es) Nuevos derivados de n-(arilsulfonil)aminoacidos que tienen una afinidad por los receptores de la bradicinina.
TR199900537T2 (xx) D�n��t�r�lm�� amino asitler, bunlar� i�eren farmas�tik preparatlar.
HUP0003690A2 (hu) Kamptotecinek polimer származékai, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
SE8004745L (sv) Nya tripeptider, som inverkar pa det centrala nervsystemet, jemte sett for deras framstellning
TR200400857T4 (tr) Yeni galantamın türevleri ve analogları
AU1930497A (en) Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
AU577206B2 (en) Conjugates of vinblastine and protein
DE60003711D1 (de) Verfahren zur herstellung von peptidzwischenprodukten
HRP20050242B1 (en) Synthetic peptides containing unnatural adamantane related amino acids for use as antitumour drugs
ES2147944T3 (es) Preparacion estereoselectiva de derivados del acido succinico, sustituidos en posicion 2, que inhiben la renina.
DE60235497D1 (de) Synthese von 2-cyanziridin-1-carbonsäureamid
ATE231161T1 (de) 6-deoxy-erythromycin-derivate, ihrer herstellung, und ihrer verwendung als arzneimitteln
SE8305306D0 (sv) Alkyl-bensylidenderivat
KR970027045A (ko) 트리에틸렌테트라아민-14^c의 제조방법

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 848011

Country of ref document: ES